Children as young as six could be offered weight loss jabs Victoza and Saxenda after trial

GLP-1 appetite-suppressing drug Liraglutide, sold under the names Victoza and Saxenda among others, was found to be "safe and effective" in children aged six to 12 despite coming with side effects of vomiting and diarrhoea